Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEST: Febuxostat vs Allopurinol in Hyperuricemia
NCT02600780Phase 4Completed
- Sponsor
- Getz Pharma
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of febuxostat in hyperuricemia (2 arms), sponsored by Getz Pharma. Primary endpoint: Serum Uric Acid Levels at 3 months. Started Nov 2013; status: completed.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT02600780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600780.